Key facts
- Notable investors include 500 Global, MS&AD Ventures, Moment Ventures.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for GenMD
- ·The full record, as it builds
Funding rounds
No funding rounds for GenMD are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GenMD
Developer of synthetic data and an AI-powered healthcare analytics platform designed to enable secure data sharing and accelerate medical research without compromising patient privacy. The company's platform includes the generation of realistic synthetic health records, compliance with HIPAA and GDPR through data anonymization, integrated data science and machine learning tools for analysis and visualization, and monetization capabilities for synthetic data assets, enabling healthcare providers, researchers, and organizations to collaborate, innovate, and derive insights while maintaining data security and regulatory compliance.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2022
- Employees
- 4
- Website
- genmd.ai/
- Ownership
- Privately Held (backing)
GenMD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GenMD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GenMD in its N-PORT filings yet. We sweep new filings monthly.